FiercePharmaAsia—JLABS’ Shanghai site, Sanofi’s Dengvaxia crisis, Astellas’ $450M DMD buy
admin 8th December 2017 Uncategorised 0Johnson & Johnson decides to put its JLABS site outside of North America in Shanghai, Sanofi faces public uproar in the Philippines over Dengvaxia’s safety issue, Astellas is taking full control of DMD expert Mitobridge, and more.
More: FiercePharmaAsia—JLABS’ Shanghai site, Sanofi’s Dengvaxia crisis, Astellas’ 0M DMD buy
Source: fierce